Provided by Tiger Fintech (Singapore) Pte. Ltd.

Capital Research Global Investors

2,153.04
+19.450.91%
Number of Gainers:69
Number of Losers:26
Number of Flat:- -
PE:- -
High:2,153.92
Open:2,133.97
Low:2,128.40
Close:2,133.60
Loading ...

Athletics-Kipyegon falls well short in bid for first sub-four-minute mile

Reuters
·
Yesterday

General Dynamics Awarded $580M Task Order From U.S. Army

Dow Jones
·
Yesterday

Mixed options sentiment in Nike with shares up 2.06%

TIPRANKS
·
Yesterday

Comcast Launches New Xfinity Internet Plans with Simple Pricing and No Contracts

Reuters
·
Yesterday

MercadoLibre Is Maintained at Positive by Susquehanna

Dow Jones
·
Yesterday

Equinix Guidance Comes Up Short But History Suggests Outlook Will Trend Higher -- Market Talk

Dow Jones
·
Yesterday

Moderately bullish activity in Meta Platforms (Facebook) with shares up 2.43%

TIPRANKS
·
Yesterday

Autodesk Inc. Unveils 2025 AI Jobs Report: Surging Demand for AI Skills Reshapes Design and Make Industries

Reuters
·
Yesterday

General Dynamics Information Technology awarded $580M task order

TIPRANKS
·
Yesterday

General Dynamics Secures $580M Contract to Bolster U.S. Army Base Security Worldwide

Reuters
·
Yesterday

General Dynamics Corp - Gdit Awarded $580 Mln Task Order to Enhance U.S. Army Base Security

THOMSON REUTERS
·
Yesterday

GE Appliances to Reshore Washing-Machine Manufacturing From China -- WSJ

Dow Jones
·
Yesterday

Europe Has Pledged to Spend More On Defense. These Stocks Are Rising. -- Barrons.com

Dow Jones
·
Yesterday

AMD Announces New Technology That Reduces Graphics Card Load

TIPRANKS
·
Yesterday

These 3 Tech Stocks Are Unstoppable Monsters

Motley Fool
·
Yesterday

BRIEF-Meta Has Hired A Highly Influential OpenAI Researcher, Trapit Bansal, To Work On Its AI Reasoning Models - Techcrunch

Reuters
·
Yesterday

Amgen’s Promising Extension Study on Dazodalibep for Sjögren’s Syndrome

TIPRANKS
·
Yesterday

Amgen’s Innovative Approach to Treating Advanced Thoracic Tumors: A Closer Look at the AMG 193 Study

TIPRANKS
·
Yesterday

Amgen’s New Study on Metastatic Colorectal Cancer: A Potential Game Changer?

TIPRANKS
·
Yesterday

Gilead and Arcus Biosciences’ Promising Phase 3 Cancer Trial Update

TIPRANKS
·
Yesterday